Skip to Content
Merck
  • Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase.

Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase.

Neuron (2014-03-19)
Jingfei Zhang, Aqsa Malik, Hyun B Choi, Rebecca W Y Ko, Lasse Dissing-Olesen, Brian A MacVicar
ABSTRACT

Complement receptor 3 (CR3) activation in microglia is involved in neuroinflammation-related brain disorders and pruning of neuronal synapses. Hypoxia, often observed together with neuroinflammation in brain trauma, stroke, and neurodegenerative diseases, is thought to exacerbate inflammatory responses and synergistically enhance brain damage. Here we show that when hypoxia and an inflammatory stimulus (lipopolysaccharide [LPS]) are combined, they act synergistically to trigger long-term synaptic depression (LTD) that requires microglial CR3, activation of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), and GluA2-mediated A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) internalization. Microglial CR3-triggered LTD is independent of N-methyl-D-aspartate receptors (NMDARs), metabotropic glutamate receptors (mGluRs), or patterned synaptic activity. This type of LTD may contribute to memory impairments and synaptic disruptions in neuroinflammation-related brain disorders.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4′-Hydroxy-3′-methoxyacetophenone, 98%
Sigma-Aldrich
Acetovanillone, ≥98%, FG